Deutsche Bank
GLUE icon

Deutsche Bank’s Monte Rosa Therapeutics GLUE Stock Holding History

Deutsche Bank’s Portfolio GLUE Stock Details GLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$816K Sell
68,387
-6,674
-9% -$114K ﹤0.01% 2351
2026
Q2 		$1.82M Buy
75,061
+27,199
+57% +$514K ﹤0.01% 1963
2026
Q1 		$787K Buy
47,862
+14,754
+45% +$282K ﹤0.01% 2324
2025
Q4 		$519K Buy
33,108
+8,537
+35% +$115K ﹤0.01% 2546
2025
Q3 		$182K Buy
24,571
+5,941
+32% +$31.5K ﹤0.01% 3110
2025
Q2 		$84K Sell
18,630
-6,220
-25% -$27.7K ﹤0.01% 3312
2025
Q1 		$115K Sell
24,850
-4,214
-14% -$25.8K ﹤0.01% 3151
2024
Q4 		$202K Buy
29,064
+6,633
+30% +$49.8K ﹤0.01% 3089
2024
Q3 		$119K Buy
22,431
+11,571
+107% +$58.4K ﹤0.01% 3155
2024
Q2 		$40.6K Sell
10,860
-2,528
-19% -$12.9K ﹤0.01% 3359
2024
Q1 		$94.4K Sell
13,388
-571
-4% -$3.39K ﹤0.01% 3195
2023
Q4 		$78.9K Hold
13,959
– – ﹤0.01% 3325
2023
Q3 		$66.9K Hold
13,959
– – ﹤0.01% 3335
2023
Q2 		$95.6K Sell
13,959
-12,319
-47% -$79.7K ﹤0.01% 3294
2023
Q1 		$205K Buy
26,278
+305
+1% +$2.12K ﹤0.01% 2988
2022
Q4 		$198K Buy
25,973
+2,481
+11% +$20.7K ﹤0.01% 2984
2022
Q3 		$192K Buy
23,492
+10,026
+74% +$92.1K ﹤0.01% 2970
2022
Q2 		$130K Sell
13,466
-2,584
-16% -$26K ﹤0.01% 3387
2022
Q1 		$225K Buy
16,050
+9,040
+129% +$126K ﹤0.01% 3198
2021
Q4 		$143K Sell
7,010
-688
-9% -$14.4K ﹤0.01% 3536
2021
Q3 		$171K Buy
+7,698
New +$221K ﹤0.01% 3647

Other funds holding GLUE

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Y-Intercept (HK)
Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Deutsche Bank's GLUE Position: Q3 2026 in Review

Deutsche Bank reduced its Monte Rosa Therapeutics (GLUE) stake by 8.9% in Q3 2026, selling an estimated $114K and leaving 68,387 shares worth $816K. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

Deutsche Bank first reported a position in GLUE in Q3 2021 and has held it in 21 quarters since. The position peaked at $1.82M in Q2 2026. 52 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.

  • Deutsche Bank held 68,387 shares of Monte Rosa Therapeutics worth $816K as of Q3 2026.
  • Deutsche Bank sold 6,674 Monte Rosa Therapeutics shares in Q3 2026, an estimated $114K.
  • Monte Rosa Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q3 2026, its #2351 holding.
  • Deutsche Bank first reported a position in Monte Rosa Therapeutics in Q3 2021 and has held it in 21 quarters since.
  • Deutsche Bank's Monte Rosa Therapeutics position peaked at $1.82M in Q2 2026.
  • 52 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.

Based on Deutsche Bank's 13F filing for Q3 2026, filed 6 Nov 2026.